CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-06 | MOORE JOHN R General Counsel | Sale | −2,351 | $10.99 | $26K | 3,000 |
| 2022-09-06 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −4,730 | 127,727 | ||
| 2022-08-08 | MOORE JOHN R General Counsel | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-08-08 | Russell Alan J Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-08-08 | Carruthers R Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-08-08 | Derakhshan Behrad Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-08-08 | Donovan Joanne M. CMO | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2022-08-08 | KOCH KEVIN President and CEO | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2022-08-03 | MOORE JOHN R General Counsel | Option exercise | +4,730 | $1.93 | $9K | 7,730 |
| 2022-08-03 | MOORE JOHN R General Counsel | Option exercise | +4,502 | $0.71 | $3K | 12,232 |
| 2022-08-03 | MOORE JOHN R General Counsel | Sale | −9,232 | $9.31 | $86K | 3,000 |
| 2022-08-03 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −4,730 | 132,457 | ||
| 2022-08-03 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −4,502 | 112,558 | ||
| 2022-07-06 | MOORE JOHN R General Counsel | Option exercise | +1,046 | $1.93 | $2K | 4,046 |
| 2022-07-06 | MOORE JOHN R General Counsel | Sale | −1,046 | $8.54 | $9K | 3,000 |
| 2022-07-06 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −1,046 | 137,187 | ||
| 2022-07-05 | MOORE JOHN R General Counsel | Option exercise | +3,684 | $1.93 | $7K | 6,684 |
| 2022-07-05 | MOORE JOHN R General Counsel | Option exercise | +4,502 | $0.71 | $3K | 11,186 |
| 2022-07-05 | MOORE JOHN R General Counsel | Sale | −8,186 | $8.35 | $68K | 3,000 |
| 2022-07-05 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −3,684 | 138,233 |
Page 18 of 26 · 509 trades